We serve Chemical Name:Ethyl(trimethyl)silane CAS:3439-38-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Ethyl(trimethyl)silane
CAS.NO:3439-38-1
Synonyms:Silane, ethyltrimethyl-;Silane,ethyltrimethyl;Aethyl-trimethyl-silan;ETHYL-TRIMETHYL-SILANE;trimethylsilylethane;Trimethyl-aethyl-silicium;Ethyl(trimethyl)silane;Trimethylethylsilane
Molecular Formula:C5H14Si
Molecular Weight:102.250
HS Code:2931900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:58.7±3.0 °C at 760 mmHg
Density:0.7±0.1 g/cm3
Index of Refraction:1.379
PSA:
Exact Mass:102.086479
LogP:3.37
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1993
Packing Group:
Contact us for information like Silane, ethyltrimethyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Trimethylethylsilane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl(trimethyl)silane Use and application,Silane,ethyltrimethyl technical grade,usp/ep/jp grade.
Related News: The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. Ethyl(trimethyl)silane manufacturer That impacts airlines’ business, making it less financially attractive for them to fly those routes to China. Ethyl(trimethyl)silane supplier The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. Ethyl(trimethyl)silane vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. Ethyl(trimethyl)silane factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.
